• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和设计针对分枝杆菌蛋白激酶 PknB 的新型潜在抗菌肽。

Identification and Design of Novel Potential Antimicrobial Peptides Targeting Mycobacterial Protein Kinase PknB.

机构信息

SilicoScientia Private Limited, Nagananda Commercial Complex, No. 07/3, 15/1, 18th Main Road, Jayanagar 9th Block, Bengaluru, 5600413, India.

Department of Bioinformatics, Rajiv Gandhi Institute of IT and Biotechnology, Bharati Vidyapeeth Deemed to be University, Pune-Satara Road, Pune, India.

出版信息

Protein J. 2024 Aug;43(4):858-868. doi: 10.1007/s10930-024-10218-9. Epub 2024 Jul 16.

DOI:10.1007/s10930-024-10218-9
PMID:39014259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11345320/
Abstract

Antimicrobial peptides have gradually gained advantages over small molecule inhibitors for their multifunctional effects, synthesising accessibility and target specificity. The current study aims to determine an antimicrobial peptide to inhibit PknB, a serine/threonine protein kinase (STPK), by binding efficiently at the helically oriented hinge region. A library of 5626 antimicrobial peptides from publicly available repositories has been prepared and categorised based on the length. Molecular docking using ADCP helped to find the multiple conformations of the subjected peptides. For each peptide served as input the tool outputs 100 poses of the subjected peptide. To maintain an efficient binding for relatively a longer duration, only those peptides were chosen which were seen to bind constantly to the active site of the receptor protein over all the poses observed. Each peptide had different number of constituent amino acid residues; the peptides were classified based on the length into five groups. In each group the peptide length incremented upto four residues from the initial length form. Five peptides were selected for Molecular Dynamic simulation in Gromacs based on higher binding affinity. Post-dynamic analysis and the frame comparison inferred that neither the shorter nor the longer peptide but an intermediate length of 15 mer peptide bound well to the receptor. Residual substitution to the selected peptides was performed to enhance the targeted interaction. The new complexes considered were further analysed using the Elastic Network Model (ENM) for the functional site's intrinsic dynamic movement to estimate the new peptide's role. The study sheds light on prospects that besides the length of peptides, the combination of constituent residues equally plays a pivotal role in peptide-based inhibitor generation. The study envisages the challenges of fine-tuned peptide recovery and the scope of Machine Learning (ML) and Deep Learning (DL) algorithm development. As the study was primarily meant for generation of therapeutics for Tuberculosis (TB), the peptide proposed by this study demands meticulous invitro analysis prior to clinical applications.

摘要

抗菌肽在多功能作用、合成可及性和靶标特异性方面逐渐优于小分子抑制剂。本研究旨在确定一种抗菌肽,通过有效地结合螺旋定向铰链区域来抑制丝氨酸/苏氨酸蛋白激酶(STPK)PknB。从公共存储库中准备了一个由 5626 种抗菌肽组成的文库,并根据长度进行了分类。使用 ADCP 的分子对接有助于找到所研究肽的多种构象。对于作为输入的每个肽,该工具输出该肽的 100 个构象。为了保持相对较长时间的有效结合,只选择那些在观察到的所有构象中始终与受体蛋白的活性位点结合的肽。每个肽都有不同数量的组成氨基酸残基;肽根据长度分为五组。在每组中,肽的长度从初始长度形式递增四个残基。基于更高的结合亲和力,在 Gromacs 中选择了五个肽进行分子动力学模拟。在动态分析和帧比较之后推断,不是较短的肽,也不是较长的肽,而是长度为 15 个残基的中间肽与受体结合良好。对选定的肽进行残基取代以增强靶向相互作用。进一步使用弹性网络模型(ENM)对新复合物进行分析,以评估新肽在功能位点固有动态运动中的作用。该研究表明,除了肽的长度外,组成残基的组合同样在基于肽的抑制剂生成中起着关键作用。该研究设想了微调肽回收的挑战以及机器学习(ML)和深度学习(DL)算法开发的范围。由于该研究主要是为结核病(TB)治疗生成药物,因此该研究提出的肽在临床应用之前需要进行细致的体外分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/f2a0f55ff430/10930_2024_10218_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/613ece08708d/10930_2024_10218_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/5ddc40981842/10930_2024_10218_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/526481463494/10930_2024_10218_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/8a06e91ed0bf/10930_2024_10218_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/4966acaf0311/10930_2024_10218_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/f2a0f55ff430/10930_2024_10218_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/613ece08708d/10930_2024_10218_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/5ddc40981842/10930_2024_10218_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/526481463494/10930_2024_10218_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/8a06e91ed0bf/10930_2024_10218_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/4966acaf0311/10930_2024_10218_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/048f/11345320/f2a0f55ff430/10930_2024_10218_Fig6_HTML.jpg

相似文献

1
Identification and Design of Novel Potential Antimicrobial Peptides Targeting Mycobacterial Protein Kinase PknB.鉴定和设计针对分枝杆菌蛋白激酶 PknB 的新型潜在抗菌肽。
Protein J. 2024 Aug;43(4):858-868. doi: 10.1007/s10930-024-10218-9. Epub 2024 Jul 16.
2
In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.计算机筛选和结构分析鉴定了与β-内酰胺类药物协同作用抑制分枝杆菌生长的细菌激酶抑制剂。
Mol Pharm. 2018 Nov 5;15(11):5410-5426. doi: 10.1021/acs.molpharmaceut.8b00905. Epub 2018 Oct 18.
3
Identification of Novel Inhibitors of Mycobacterium tuberculosis PknG Using Pharmacophore Based Virtual Screening, Docking, Molecular Dynamics Simulation, and Their Biological Evaluation.基于药效团的虚拟筛选、对接、分子动力学模拟及生物评价鉴定结核分枝杆菌 PknG 的新型抑制剂。
J Chem Inf Model. 2015 Jun 22;55(6):1120-9. doi: 10.1021/acs.jcim.5b00150. Epub 2015 May 21.
4
Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages.核盘菌素抑制结核分枝杆菌的蛋白激酶G并损害其在巨噬细胞中的生长。
Tuberculosis (Edinb). 2017 Mar;103:37-43. doi: 10.1016/j.tube.2017.01.001. Epub 2017 Jan 12.
5
Targeting PknB, an eukaryotic-like serine/threonine protein kinase of Mycobacterium tuberculosis with phytomolecules.以植物化合物为靶标,针对结核分枝杆菌中具有真核样丝氨酸/苏氨酸蛋白激酶特性的 PknB。
Comput Biol Chem. 2017 Apr;67:200-204. doi: 10.1016/j.compbiolchem.2017.01.003. Epub 2017 Jan 9.
6
NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.NU-6027 通过靶向蛋白激酶 D 和蛋白激酶 G 抑制结核分枝杆菌的生长。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00996-19. Print 2019 Sep.
7
In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of .基于计算机的蛋白激酶 B(PknB)抑制剂的可能抑制剂的鉴定
Molecules. 2021 Oct 12;26(20):6162. doi: 10.3390/molecules26206162.
8
A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity.一种具有抗结核活性的新型蛋白激酶抑制剂 IMB-YH-8。
Sci Rep. 2017 Jul 11;7(1):5093. doi: 10.1038/s41598-017-04108-7.
9
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.PknB仍然是结核分枝杆菌易感菌株和耐多药菌株药物开发的一个重要且保守的靶点。
Ann Clin Microbiol Antimicrob. 2017 Aug 18;16(1):56. doi: 10.1186/s12941-017-0234-9.
10
Structural and Genetic Analyses of the Mycobacterium tuberculosis Protein Kinase B Sensor Domain Identify a Potential Ligand-binding Site.结核分枝杆菌蛋白激酶B传感器结构域的结构与遗传分析确定了一个潜在的配体结合位点。
J Biol Chem. 2016 Oct 28;291(44):22961-22969. doi: 10.1074/jbc.M116.731760. Epub 2016 Sep 6.

引用本文的文献

1
Generative AI, molecular docking and molecular dynamics simulations assisted identification of novel transcriptional repressor EthR inhibitors to target .生成式人工智能、分子对接和分子动力学模拟辅助鉴定新型转录阻遏物EthR抑制剂作为靶点
Heliyon. 2025 Feb 10;11(4):e42593. doi: 10.1016/j.heliyon.2025.e42593. eCollection 2025 Feb 28.

本文引用的文献

1
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery.在药物递送变革的背景下整合人工智能用于药物发现。
Life (Basel). 2024 Feb 7;14(2):233. doi: 10.3390/life14020233.
2
Deep learning for advancing peptide drug development: Tools and methods in structure prediction and design.深度学习在推进肽类药物研发中的应用:结构预测和设计中的工具和方法。
Eur J Med Chem. 2024 Mar 15;268:116262. doi: 10.1016/j.ejmech.2024.116262. Epub 2024 Feb 19.
3
The antimicrobial peptide database is 20 years old: Recent developments and future directions.
抗菌肽数据库已有20年历史:近期进展与未来方向。
Protein Sci. 2023 Oct;32(10):e4778. doi: 10.1002/pro.4778.
4
Infectious diseases and the Sustainable Development Goals: progress, challenges and future directions.传染病与可持续发展目标:进展、挑战及未来方向
Nat Rev Microbiol. 2023 Oct;21(10):626-627. doi: 10.1038/s41579-023-00954-7.
5
TLK1-mediated RAD54 phosphorylation spatio-temporally regulates Homologous Recombination Repair.TLK1 介导的 RAD54 磷酸化时空调节同源重组修复。
Nucleic Acids Res. 2023 Sep 8;51(16):8643-8662. doi: 10.1093/nar/gkad589.
6
Discovering highly potent antimicrobial peptides with deep generative model HydrAMP.利用深度生成模型HydrAMP发现高效抗菌肽。
Nat Commun. 2023 Mar 15;14(1):1453. doi: 10.1038/s41467-023-36994-z.
7
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.结核分枝杆菌的致病机制:对新药研发的启示
Mol Biomed. 2022 Dec 22;3(1):48. doi: 10.1186/s43556-022-00106-y.
8
Peptide-based drug discovery: Current status and recent advances.基于肽的药物发现:现状和最新进展。
Drug Discov Today. 2023 Feb;28(2):103464. doi: 10.1016/j.drudis.2022.103464. Epub 2022 Dec 5.
9
RING 3.0: fast generation of probabilistic residue interaction networks from structural ensembles.RING 3.0:从结构集合中快速生成概率残基相互作用网络。
Nucleic Acids Res. 2022 Jul 5;50(W1):W651-W656. doi: 10.1093/nar/gkac365.
10
Therapeutic peptides: current applications and future directions.治疗性肽:当前的应用及未来方向。
Signal Transduct Target Ther. 2022 Feb 14;7(1):48. doi: 10.1038/s41392-022-00904-4.